The suc1/Cks proteins are well-conserved regulatory components of cyclin-dependent kinases 1 and 2 (CDK1/2). These small molecular mass proteins form a stable complex with CDK1/2 and are essential for normal regulation of CDKs during the cell division cycle and for degradation of p27 kip1 . Despite the high degree of homology between the nine known CDKs, only CDK1, CDK2 and, to a lesser extent, CDK3 are able to bind to the suc1/Cks proteins. No additional suc1/Cks-related proteins interacting with other CDKs have been reported. We have purified, from starfish oocytes, a 15 kDa protein, p15 CDKÀBP , which cross-reacts with anti-Cks antibodies (L. Azzi, L. Meijer, A.C. Ostvold, J. Lew, J.H. Wang, J. Biol. Chem. 269 (1994)). Following microsequencing of internal peptides and generation of corresponding oligonucleotides we cloned two cDNAs encoding two closely related proteins, p15A and p15B. The predicted protein sequences display distant but distinct homology with the Suc1/Cks proteins, including the genuine starfish Cks homologue protein, p9
Introduction
The division cycle of eukaryotic cells is marked by distinct transitions between the end of the ¢rst growth phase (G 1 ) and DNA synthesis (S phase), and between the end of the second growth phase (G 2 ) and mitosis (M phase). The past decade has witnessed a tremendous surge in knowledge of factors controlling the G 1 /S and the G 2 /M transitions of the cell cycle [2^4] . In particular, transition of the G 2 / M boundary is clearly under control of the M phase promoting factor, a heterodimeric serine/threonine kinase ubiquitous in all eukaryotes. In yeast, a single catalytic subunit (termed Cdc28 in Saccharomyces cerevisiae, and cdc2 in Schizosaccharomyces pombe) controls both the G 2 /M and G 1 /S transitions by in-teracting selectively with positive regulatory subunits known as cyclins [5] . Higher eukaryotes utilise a more complex scheme involving several di¡erent catalytic subunits interacting with multiple classes of cyclins to ¢nely tune cell cycle control mechanisms to additional in£uences such as hormones and growth factors [6^8] .
The ¢rst co-factor interacting with cyclin-dependent kinases (CDKs) was identi¢ed as a high copy suppressor of temperature sensitive cdc2 mutations in S. pombe [9] . A protein highly related to the product of the S. pombe suc1 gene (p13 suc1 ), cdc28 kinase subunit 1 (CKS1), was isolated from S. cerevisiae in a similar manner [10] . Homologues to the yeast suc1/ CKS1 proteins have since been identi¢ed in several other organisms [11^17] . The high degree of sequence conservation observed between suc1/Cks proteins from evolutionary distant organisms is indicative of a highly conserved and important function for these proteins. Null mutations of suc1 and CKS1 are lethal in yeast [18, 19] , whereas overexpression interferes with progression of G 1 in yeast [17] and oocyte maturation in Xenopus [20] . Controlled repression of CKS1 in S. cerevisiae does not a¡ect cdc28 kinase activity [21] while the cdc2 inhibitory e¡ect of suc1 repression in S. pombe apparently depends on the cyclin partner of cdc2 [22] . Recently, the p9 CKShs2 binding e⁄ciency to CDK1 has been shown to be dependent on both cyclin B association and CDK1 Thr160 activating phosphorylation [23] . Crystal structures for suc1 and its two human homologues have been resolved [24^26] . Hexameric assembly of the human protein in part has suggested a sca¡olding role of this protein for cell cycle control enzymes [26] . In contrast, suc1 does not form hexamers [25] , indicating that alternative models must be considered. However, the suc1/Cks proteins seem to share the property to dimerise through a L strand interchange region, the L hinge motif [27, 28] . This dimerisation process is involved in the regulation of the suc1/Cks proteins binding to the CDKs [27^30]. The CDK2 binding a⁄nity for multimeric p9 CksHs2 is much weaker compared to the monomeric a⁄nity [30] .
The structural data from CDK2-CksHs1 co-crystals [31] have suggested an adaptor function for these small CDK co-factors [32] . Indeed the CDK2-CksHs1 structure shows that p9
CksHs1 binding to CDK2 does not induce conformational change in the kinase but provides an expanding recognition surface with a sequence-conserved phosphate binding region, located on the same side as the CDK catalytic site [31] . This sequence is structurally well conserved within the suc1/Cks protein family [28] . Studies on the e¡ect of the loss of suc1 function [22] or of depletion of Xe-p9 from mitotic Xenopus egg extracts [16] have shown an arrest in mitosis and accumulation of mitotic cyclins and proposed a putative role for suc1/cks protein in cyclin degradation. P13 suc1 binds the activated cyclosome [33] and recently Xe-p9, the Xenopus suc1/Cks homologue has been shown to regulate the phosphorylation of the anaphase promoting complex (APC) by CDK1/cyclin B [34] . These results converge towards a substrate targeting function for the suc1/Cks protein family. However, in S. cerevisiae, the Cks1 subunit does not associate with APC but associates directly with the proteasome [35] . Very recently Cks1 was demonstrated to be absolutely required for SCF Skp2 -mediated ubiquitinylation, targeting and destruction of p27 Kip1 [36^38]. In a previous work, we set out to purify a suc1 homologue from star¢sh oocytes. A 15 kDa protein was puri¢ed based on cross-reactivity with an antiserum directed toward p9
CKShs2 [1] . However, this protein did not interact with CDK1 or CDK2 but was found to bind to a 35 kDa star¢sh enzyme crossreacting with anti-PSTAIRE antibodies [1, 39] . Herein we describe the molecular cloning of the gene encoding this 15 kDa CDK-binding protein and further characterise some of its properties. In addition, we describe the molecular cloning of the star¢sh p9 CksHs1 homologue cDNA, p9
CksMg .
Materials and methods

Protein puri¢cation and sequencing
Puri¢cation of p15 from star¢sh oocytes was accomplished as previously described [1] . The puri¢ed protein was digested with thermolysin and the peptides separated by HPLC. Peptide microsequencing was performed by Dr. J. D'Alayer, at the Pasteur Institute, Paris.
p15
CDKÀBP cDNA cloning
Total RNA was prepared from star¢sh (Marthasterias glacialis) G 2 phase oocytes according to the methods of [40] . Approx. 5 Wg of total RNA were annealed with 50 pmol of random hexamers and reverse transcribed using AMV-reverse transcriptase (Boehringer Mannheim) as described [41] . Reverse transcribed total RNA was then utilised as a template for polymerase chain reaction (PCR) ampli¢ca-tion of p15 cDNA sequences. Oligonucleotide primers based on p15 peptide sequence data and minimised for degeneracy were employed using standard PCR reaction conditions. The PCR primers, dATGATYGGIAARCCHGCIAARCCHTTTGAT-MG and dYTTIACRTTGTACATICCCCA, were annealed to template cDNA at 48 ‡C and primer extended at 71 ‡C with Taq DNA polymerase (Promega) for 30 cycles. A PCR product was obtained, labelled by incorporation of [ 32 P]dATP (Amersham) and employed as a hybridisation probe to screen approx. 250 000 plaque forming units (pfu) of a star¢sh cDNA library. The star¢sh library was prepared by the Pasteur Institute Molecular Oncology Unit (Lille). Star¢sh cDNA synthesised from poly(A) þ selected RNA was inserted into the EcoRI site of V NM-1149 and phage were ampli¢ed by infection of C600-h£ bacteria. The cDNA library was screened using standard procedures as described [41] . Filters were washed at a high level of stringency: 65 ‡C, 30 mM NaCl in sodium citrate bu¡er pH 8.0. The nucleotide sequence was obtained for one of three positive clones by excising the V EcoRI insert, subcloning into Bluescript SK3 (Stratagene) and sequencing with a T7 Sequenase kit (Pharmacia) employed according to the manufacturer's instructions. This clone (p15A) was used to re-screen the same star¢sh cDNA library for which ¢nal washing of the ¢lters was at 58 ‡C, 80 mM NaCl in sodium citrate pH 8.0. Thirty positive clones were isolated and re-screened by both single lane (ddATP) sequencing and Southern hybridisation at variable stringency. This secondary screening identi¢ed an additional p15 cDNA clone which was also sequenced as described above.
p9
CKS cDNA cloning Star¢sh G 2 phase oocyte total RNA was also reverse transcribed with an oligo(dT) primer and the resulting cDNA then used as a template for PCR ampli¢cation of cDNA encoding the star¢sh homologue of S. pombe p13 suc1 . The primers used for PCR were dGAGGGAGCCG ARTAYMGNCAYGTN-ATG and dATGGAATTCRAANARNARNATRT-GNGGYTCNGG. The resulting PCR product was found to encode a predicted peptide sequence with similarity to S. pombe p13 suc1 and was consequently used as a hybridisation probe to screen a star¢sh genomic DNA library. The genomic DNA library was constructed from Sau3AI partial digests of star¢sh (M. glacialis) genomic DNA inserted into the BamHI site of V dash-II (Stratagene). This library was also prepared by the Pasteur Institute Molecular Oncology Unit (Lille).
RNA analysis
Total RNA was prepared from tissue samples (5 g) frozen in liquid nitrogen, pulverised and then lysed with 4 M guanidinium-isothiocyanate as described [40] . The RNA was quanti¢ed by absorbance at 260 nm, 10 Wg samples were denatured and resolved by electrophoresis through 1% agarose gels containing 2.2 M formaldehyde. Following transfer to a charged nylon membrane (Genescreen-Plus, Dupont), the RNAs were hybridised with p15 cDNAs containing [
32 P]dATP (Amersham) incorporated by priming with random hexamers. Hybridisations were performed at 65 ‡C in 5USSC (750 mM NaCl, 75 mM sodium citrate pH 7.0) plus 0.2% SDS, 100 Wg/ml denatured salmon sperm DNA (Sigma) for 18 h. Filters were washed to a ¢nal stringency of 0.1USSC, 0.2% SDS at 65 ‡C for 15 min. Loading controls were performed by staining duplicate gels with ethidium bromide.
Immunoblotting p9
CksHs1 -Sepharose and p15 CDKÀBP -Sepharose beads were prepared as previously described [1] . Expression of recombinant p15 was performed by subcloning an RCA-1/BamHI fragment of pBluescriptp15A into pGEX-4T1 (Pharmacia), and an EcoRI fragment of pBluescript-p15B into the EcoRI site of pGEX-2T followed by expression as GST-fusion proteins according to the manufacturer's instruc-tions. The RcaI restriction enzyme site in p15A was obtained by introducing a C to T point mutation at position 94.
Extracts of star¢sh oocytes in G 2 or M phase were prepared as previously described [1] . Recombinant p15A and p15B bound to glutathione agarose (Sigma), or p9
CksHs1 -Sepharose, or p15 CDKÀBP -Sepharose were mixed with oocyte extracts (generally 10 Wl of packed beads per 500 Wl of extract) for 1 h at 4 ‡C. Other extracts (insect cell lysate expressing CDK6/ cyclin D2, Escherichia coli expressed GST-Pho85 and Drosophila embryo nuclear extracts) were also loaded on control beads (p9 CksHs1 -Sepharose or Sepharose CL4B) or on p15 CDKÀBP -Sepharose. Beads were then collected by centrifugation and washed three times with wash bu¡er (150 mM NaCl, 50 mM Tris^HCl pH 8.0, 0.05% Tween 20 or 25 mM HEPES-K þ , 0.1.mM EDTA, 12.5 mM MgCl 2 , 100 mM KCl, 1 mM DTT, 1 mM sodium bisulphite, 1 mM benzamidine, 2 mM PMSF, 1% Nonidet P-40, pH 7.6) for beads loaded with nuclear extracts. Proteins bound to the beads were then separated by SDS^PAGE, transferred to nitrocellulose and immunoblotted with the appropriate antibodies. Antibodies employed included: anti-PSTAIRE [42] (a generous gift of Dr. Yamashita), a mouse monoclonal antibody; anti-p15, a rabbit polyclonal antibody produced by Neosystems and a⁄nity puri¢ed by adsorption to p15 CDKÀBP -Sepharose, anti-CDK6, anti-CDK7, anti-CDK8, anti-cyclin C and anti-CDK1.
Results
cDNA cloning of p15 CDKÀBP
We have previously described the puri¢cation of a CDK4-and CDK5-binding protein from star¢sh oocytes [1] . This protein was further puri¢ed by preparative gel electrophoresis, transferred to nitrocellulose and the appropriate band excised and microsequenced. Four peptide sequences (Fig. 1) were obtained of which two were chosen for the design of degenerate oligonucleotide primers (see Section 2). These primers were employed for the ampli¢cation of a 225 bp fragment from reverse transcribed star¢sh oocyte RNA. This fragment was then used to screen a star¢sh oocyte cDNA library. A poly(A) containing cDNA was obtained that included a predicted open reading frame for a protein of 139 amino acids (Fig. 1A) . The predicted protein sequence from this clone (p15A) contained amino acids which showed some similarity to peptide sequences obtained by microsequencing of p15 CDKÀBP from star¢sh oocyte extracts. However, signi¢cant di¡erences were observed between the peptide microsequence data and the cDNA predicted p15 CDKÀBP sequence. One peptide was entirely absent from the predicted sequence for p15A (compare Fig.  1A,B) . Consequently, we conducted a second screen for additional p15 cDNA. The p15A cDNA was used to re-screen the star¢sh cDNA library and from 30 additional positive clones several were found to contain an additional p15 cDNA sequence (p15B, Fig. 1B ). Nucleotide sequence analysis of this second p15 cDNA indicated that it also contained an open reading frame encoding a predicted protein sequence of 144 amino acids. The predicted amino acid sequence of p15B was observed to have a much closer match to the p15 CDKÀBP microsequence data, containing all four peptide sequences (Fig. 1B) . Reanalysis of the microsequencing data (not shown) indicated that the two remaining mismatches within the predicted sequence of p15 CDKÀBP (Ala and Arg) are possibly due to ambiguous chromatographic peaks.
Star¢sh suc1 homologue cloning and sequence
analysis of the p15A and p15B with the p13 suc1 / p9
Cks family of proteins
Using primers based on the highly conserved suc1 homologues, we succeeded in amplifying a partial cDNA for a p13 homologue from star¢sh reverse transcribed RNA. However, despite extensive e¡orts with additional primers no additional sequence could be obtained from reverse transcribed RNA. We were also unsuccessful in obtaining a star¢sh p9 cDNA clone by employing the p9 PCR product as a hybridisation probe to screen an oligo(dT) primed star¢sh cDNA library. However, a star¢sh genomic DNA library was screened with the p9 PCR product and an additional clone was detected. This 12 kb genomic clone from star¢sh contained the p9 sequence ampli¢ed by PCR and also extended our sequence information towards the 3P end of the star¢sh p9 CksMg coding sequence (Fig. 2) . Alignment of p9 CksMg with other suc1 homologues demonstrates that the star¢sh protein is also highly conserved. Comparing the conserved domain, the star¢sh p9
CksMg protein shows 66% identity with human p9
CksHs1 , 62% with p9
CksHs2 , 62% with the Xenopus p9 CksXl , and 47% and 48% with the yeast proteins p13 suc1 and p18 CKS1 , respectively (Fig. 2) .
Data base searches have not allowed the identi¢-cation of any proteins with signi¢cant homology to p15. However, alignment of the predicted star¢sh p15 sequences with the suc1/Cks proteins demonstrates that both p15A and p15B have two distinct regions presenting limited homology with the suc1/ Cks family (45% of identity for YSICLSPDKYE with suc1 and 54% with CKS1, WRHNYYDERW-GMY present less than 24% of identity with suc1 [12] , Drosophila melanogaster, CksDm [14] , Xenopus laevis, CksXl [16] , Mus musculus, CksMm (Marra et al., P56390), Homo sapiens, CksHs1 and CksHs2 [17] , Physarum polycephalum, CksPp [11] , and Arabidopsis thaliana, CksAt [13] . The consensus sequence for the suc1/Cks family is shown in uppercase. Lowercase within the consensus indicates amino acid residues which are 'preferred' in the majority of suc1/Cks proteins. The CKS1 protein secondary structure [28] is indicated below the consensus sequence, K helix (K) and L strand (L). The relationship between p15B and suc1/Cks proteins is shown with uppercase bold type indicating strict conservation between all proteins, lowercase indicating preferred residues and asterisk indicating conserved similar amino acids. Where similar amino acids are grouped as hydrophobic non-polar, G, A, V, L, I, P, F, M, W, C; hydrophilic, N, Q, S, T, Y; acid, D, E; basic, K, R, H. and CKS1) (Fig. 2) . The highest degree of similarity is observed between p15 and the yeast suc1 and CKS1 proteins which, when compared to other suc1 homologues, have an N-terminal extension of 20 amino acids as well as an internal insertion of nine amino acids. Additionally, CKS1 has a C-terminal extension of approx. 35 amino acids of which 20 are glutamines. Like suc1 and CKS1, p15A and p15B are both N-terminally extended, and some similarity is observed between the p15 sequences and CKS1 in this segment. Both p15 sequences also contain a C-terminal extension but with little similarity to CKS1 as there are only two adjacent glutamines. In contrast the star¢sh p9
CksMg protein compares much more favourably with the smaller suc1 homologues of Physarum, Patella, Drosophila, Xenopus, mouse and human. The important number of cysteine residues present in both p15 sequences should also be noticed. These residues are not conserved within the Suc1/Cks protein sequences.
p15 CDKÀBP transcripts are restricted to oocytes
The p15B cDNA is 1560 bp and corresponds closely to the relative molecular size of p15B mRNA as estimated by migration through agarose gel (Fig. 3I) . The transcripts for both p15A and p15B were detected exclusively in star¢sh oocytes and we did not detect mRNA for these proteins in mature or regenerating tissues (Fig. 3I,II A , lanes 1 and 2) . A relatively low level of p15B message was detected in the poly(A) 3 fraction of G 2 oocytes, indicating that this message is fully polyadenylated at this stage (Fig. 3I A , lane 6) . However, the same poly(A) 3 RNA fraction was observed to contain substantially more p15A message (Fig. 3II A , lane 6 ), suggesting that a fraction of the p15A message pool is not polyadenylated in G 2 oocytes. Additionally, the p15A cDNA is 1937 bp and does not correspond well to the p15A message size as observed by Northern blotting (Fig.  3II A ) . As estimated by Northern blotting, p15A mRNA appeared to be smaller than p15B mRNA (compare Fig. 3I A and II A , lanes 4) . This result and the observations that a substantial portion of p15A transcripts remained in the poly(A) 3 fraction, and the lack of p15A message in M phase poly(A) þ mRNA suggest that p15A transcripts are highly labile and partially degraded even in G 2 oocytes.
Interestingly, the star¢sh p9 CksMg message was not detected in P or M phase oocytes (Fig. 3III, lanes 4  and 5) , nor was the corresponding protein detected by Western blotting [1] . This result is, perhaps, not surprising given the di⁄culty experienced in amplify- ing and cloning full length star¢sh p9
CksMg cDNA from oocyte mRNA (described in Section 2). Consequently, the partial p9 cDNA originally ampli¢ed from oocyte RNA was likely derived from a genomic DNA contamination. Star¢sh p9
CksMg message was detected in immature oocytes (Fig. 3III, lane 1) . These oocytes are morphologically smaller and darker in colour than mature oocytes and they do not undergo maturation in the presence of 1-methyladenine. The presence of star¢sh p9 mRNA uniquely in immature oocytes suggests a specialised function for this protein in the initiation and/or progression of early phases of meiotic division before the G 2 arrest.
Recombinant p15B possesses the same properties
as puri¢ed p15 CDKÀBP and binds a star¢sh PSTAIRE-immunoreactive protein Both p15A and p15B were expressed in E. coli as fusion proteins with glutathione S-transferase. These recombinant proteins were e⁄ciently expressed, yielding products that migrated through SDSP AGE with their predicted relative molecular mass (data not shown) and which were detected by antip15 sera (Fig. 4) . When mixed with star¢sh oocyte extracts, p15
CDKÀBP was observed to bind a PSTAIRE-immunoreactive protein of approx. 34 kDa (Fig. 5, lane 4) . Additionally, the GST-p15B fusion protein was capable of binding to an anti-PSTAIRE-immunoreactive protein in star¢sh oocyte extracts that had been depleted of CDK1/2 by four successive rounds of binding to p9
CksHs1 -Sepharose (Fig. 5, lane 5) . Despite approx. 76% identity between p15A and p15B we did not observe binding of an anti-PSTAIRE-immunoreactive protein to GST-p15A.
p15
CDKÀBP binds several CDKs
As described previously [1, 36] , p15 CDKÀBP does not bind CDK1, CDK2 or CDK3. However, p15 CDKÀBP binds both CDK4 and CDK5 [1] . We looked at other CDKs for possible binding to p15 CDKÀBP . Nuclear extracts containing CDK1, CDK7 and CDK8 were loaded on control-Sepharose and p15
CDKÀBP -Sepharose beads, the bound and unbound proteins were resolved by SDS^PAGE and immunoblotted with di¡erent antibodies, anti-CDK8, anti-CDK7, anti-cyclin C and anti-CDK1 antibodies (Fig. 6I ). CDK8 as well as cyclin C bind strongly to p15 CDKÀBP -Sepharose, CDK7 binds weakly to p15 CDKÀBP . We also loaded insect cell lysates containing the expressed CDK6/cyclin D2 complex on p15 CDKÀBP -Sepharose beads or p9
CksHs1 -Sepharose. CDK6 also binds to p15 CDKÀBP -Sepharose but not to p9 CksHs1 -Sepharose (Fig. 6II, top) . In S. cerevisiae, Pho85 has been described as a CDC28-related protein with a PSTAIRE motif [43] . E. coli extracts containing GST-Pho85 were loaded on p15 CDKÀBP -Sepharose and p9 CksHs1 -Sepharose and the bound material was analysed by Western blotting with anti-PSTAIRE antibodies (Fig. 6II, bottom) . GST-Pho85 binds well to p15 CDKÀBP -Sepharose but very weakly to p9 CksHs1 -Sepharose.
Discussion
p15 CDKÀBP shows di¡erent isoforms
We have identi¢ed two cDNA encoding similar proteins, p15A and p15B. In addition a third cDNA (data not shown) was cloned that possessed a coding sequence identical to p15A but contained a di¡erent 3P non-coding sequence. These data are reminiscent of results obtained by Richardson et al. [17] who identi¢ed more than one suc1 homologue in humans. Clearly the two forms of star¢sh p15 CDKÀBP perform di¡erent functions as only p15B was observed to bind to a PSTAIRE signal. Again, this is similar to results reported for p9
CksHs1 and p9 CksHs2 , the human homologues of p13 suc1 [17] . These two proteins are 81% identical yet possess distinct biochemical characteristics and consequently are likely to have unique molecular functions. We conclude that the p15B sequence corresponds to the PSTAIRE-binding p15 CDKÀBP protein puri¢ed from star¢sh oocytes [1] . CDK5-binding protein [1] . We here show that p15 CDKÀBP also binds CDK6, CDK8 and Pho85. CDK1, 2 and 3 are unable to bind to p15 CDKÀBP [1] . p15 CDKÀBP seems to be able to bind only the CDKs which do not bind to the suc1/Cks protein family. p15
CDKÀBP also binds CDKX, a 35 kDa star¢sh oocyte protein which cross-reacts with the anti-PSTAIRE antibodies [1] . This protein shows interesting characteristics which di¡er from the properties of other CDKs [39] .
p15
CDKÀBP is not a kinase inhibitor We checked for the possible inhibitory e¡ect of p15 CDKÀBP on the star¢sh prophase oocyte HMG I kinase activity bound to p15 CDKÀBP and on CDK4/ cyclin D1 [39] . No inhibitory e¡ect was observed, even with the highest concentration of p15 CDKÀBP although p16
INK4A , used as control, clearly inhibits the CDK4/cyclin D1 kinase (data not shown).
Expression of star¢sh p15
CDKÀBP isoforms and p9
CksMg mRNA
The mRNA for CksHs1 and CksHs2 are di¡eren-tially expressed [17] , their three-dimensional structures are di¡erent [24, 26] ; CksHs2 forms hexamers in solution whereas CksHs1 is monomeric [24, 26] . The mRNAs for p15A and p15B appear to be maternal transcripts as we did not observe these mRNAs in tissues other than oocytes. However, the partially polyadenylated state of p15A suggests that p15A and p15B may be subject to di¡erential translation during oocyte maturation. The absence of polyadenylated p9
CksMg mRNA together with the lack of immunoreactive p9 in mature G 2 arrested star¢sh oocytes suggests that this protein is not expressed during the latter stages of star¢sh oocyte maturation. Alternatively, it is possible that our anti-p9 sera do not recognise star¢sh p9
CksMg , a rather unlikely possibility, or that the p9 CksMg mRNA is highly labile in mature star¢sh oocytes and thus degraded or otherwise below the detection limits of our Northern assays. Nevertheless, the level of star¢sh p9
CksMg message was su⁄ciently elevated in immature oocytes to be adequately detected. These results suggest that p9
CksMg may have a speci¢c role during the early stages of star¢sh oogenesis and/or expression is inhibited or at very low levels in mature oocytes and other tissues.
p15
CDKÀBP shows weak yet signi¢cant homology with the suc1/Cks family proteins Although the homology between p15A/p15B and the suc1/Cks family of proteins is weak, we believe that there is an evolutionary relationship between these proteins. Two regions that are more highly conserved between p15B and suc1/Cks proteins are predicted to form L sheets (data not shown) and are found between Ser39 and Leu56, and between Trp89 and Arg105 of p15B. Crystallographic data have recently shown that the corresponding regions in CksHs1 also form L sheets [24, 28] . Co-crystals of CDK2 and CksHs1 indicate that these regions contain residues directly involved in the association of CksHs1 with CDK2 [31] . Furthermore, the suc1/Cks protein family shows oligomerisation properties which seem to play important roles in the function of suc1/Cks proteins [27, 28, 31, 26, 30] . These properties are in relation with the well conserved motif HXPEPH which confers to the molecule a L hinge structure involved in the di¡erent conformations of the monomeric and oligomeric forms [27, 28] . The corresponding motif in p15B is well conserved in its chemical properties and we have also observed on SDS^PAGE loaded with p15 CDKÀBP puri¢ed protein, a 30 kDa band with the stronger 15 kDa band (Fig. 4) . However, contrary to the suc1/Cks proteins, the p15 A/B sequences do not present the critical proline residues shown involved in the monomer/ dimer switch of the domain swapping protein family [44] . While the overall structure within the two 'CDK contact regions' of p15 CDKÀBP may have been conserved, there are substantial di¡erences. The critical residues in CDK contact region 1 of CksHs1 include Tyr7, Tyr12 and Tyr19, and acidic residues (Asp and Glu) at positions 13^15. Although p15B does not have identity with CksHs1 at these particular residues, a similar linear arrangement of tyrosine and charged residues has been conserved within the homologous region of p15B. It should be noted, however, that the two regions of CDK2 contact with CksHs1, CDK2 amino acids 205^219 and 232^247, are not among the most highly conserved motifs observed within the CDK family. Consequently, if par-allel regions of CDK4, 5, 6 and 8 are utilised for binding to p15 CDKÀBP then alternative motifs must be employed by p15 CDKÀBP . Nevertheless, global structural features are often conserved within proteins that share a functional commonality. In S. pombe, p13 suc1 also has a similar single domain fold composed of four central L sheets with exposed aromatic residues [25, 28] . It is interesting that the accessibility of aromatic residues is believed to be important for protein^protein interactions in general [25, 28, 45] , and important for the function of suc1/ Cks family proteins in particular [25, 28] . Finally, it is tyrosine residues within p15 sequences that show the best positional conservation in comparison to suc1/Cks family proteins.
Because p15A recombinant protein does not bind to CDKX contrary to p15B, some important residues involved in these binding properties have to be found in the residues of p15B di¡erent from those of p15A. This di¡erence of binding could be due to one di¡erent residue only without alteration of the protein structure as shown for mutation of the p9 CksHs2 Glu63 into Gln which eliminates binding of CDK1 and CDK2 [30] .
In conclusion, we have identi¢ed in this study the cDNA clones for two star¢sh oocyte proteins (p15 CDKÀBP ) which were previously shown to have unique CDK-binding properties [1, 39] . Our results extend the CDK-binding properties of p15 CDKÀBP . Indeed, in addition to the ability to bind both mammalian CDK4 and CDK5, and a star¢sh oocyte protein named CDKX [1, 36] , p15 CDKÀBP was also observed to associate with other CDKs such as CDK6, CDK8 and the yeast Pho85 protein.
The amino acid sequence of p15A/p15B shows weak but signi¢cant homologies with the suc1/Cks protein family. Recent studies have shown the importance of Xenopus Cks proteins in targeting the activated CDK2/cyclin A complex towards the APC [34] and in targeting p27
Kip1 to SCF Skp2 -mediated ubiquitinylation and destruction [36, 38, 37] . p13 suc1 stimulates the phosphorylation of the cyclosome required for full activation of this complex [46] . Furthermore, in Xenopus oocytes the suc1/Cks homologue, p9
CksXl , has also been shown to stimulate the phosphorylation (by the CDK1/cyclin B complex) of proteins such as Wee1, Myt1 and cdc25, important for the G 2 /M phase transition [47] . It will be interesting to investigate these possible functions for p15 CDKÀBP .
